Skip to main content

Find Clinical Trials

Home
Conditions
SCLC, Extensive Stage

Clinical trial condition

SCLC, Extensive Stage

Explore clinical trials studying SCLC, Extensive Stage. Study availability and eligibility vary by location and protocol.

23 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

SCLC, Extensive Stage trial results

Not Yet Recruiting

Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small Cell Lung Cancer Resistant to Second-line and Above Treatment

NCT07632209

Conditions: SCLC, Extensive Stage
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer

NCT07538271

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Anlotinib in Cross-line Treatment of NSCLC and SCLC

NCT07400575

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

NCT07308379

Conditions: SCLC, Extensive Stage, Toripalimab
Locations: Not specified

View Trial Details

Not Yet Recruiting

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

NCT07141771

Conditions: SCLC, Extensive Stage
Locations: Not specified

View Trial Details

Not Yet Recruiting

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

NCT06793228

Conditions: SCLC, Extensive Stage
Locations: The First Affiliated Hospital of Henan University of Science and Technolog Luoyang, Henan, China

Xinxiang Central Hospital Xinxiang, Henan, China

Henan cancer hospital, Zhengzhou, Henan, China

Zhengzhou Third People's Hospital" Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

NCT06768307

Conditions: Chemotherapy, Immunotherapy, Radiotherapy, +1 more
Locations: Peking University Cancer Hospital and Institute Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer

NCT06620796

Conditions: SCLC, Extensive Stage
Locations: Not specified

View Trial Details

Completed

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

NCT04660097

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Sixth People's Hospital of Luoyang Luoyang, Henan, China

Henan Tumor Hospital Zhengzhou, Henan, China

View Trial Details

Completed

Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

NCT04221529

Conditions: SCLC, Extensive Stage
Locations: Klinikum Klagenfurt Klagenfurt, Austria

Universitätsklinikum Krems Krems, Austria

Karl Landsteiner Institut für Lungenforschung und Pneumologische Onkologie c/o Wilhelminenspital der Stadt Wien Vienna, Austria

St. Josef Hospital Bochum, Germany

View all 19 locations

View Trial Details